As of January 2026 Apellis Pharmaceuticals has a market cap of NZ$4.48 Billion. This makes Apellis Pharmaceuticals the world's 4298th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jan 13th, 2026 the market cap of Apellis Pharmaceuticals was reported to be: